FDA launches pilot to speed drug approvals as Roche expands Boston research hub
The FDA opens applications for a program to shorten drug approval timelines while Roche expands its Boston footprint and Sanfilippo syndrome receives a new gene therapy.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
3 publishers have covered this in 12 articles since 15 Sept 2026. STAT published first, on 15 September at 14:00 UTC; Fortune followed 52h 04m later. The most recent article, from STAT, appeared on 18 September at 13:42 UTC.
Outlets reporting it: STAT, Fortune, KFF Health News.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
- STATSTAT+: FDA takes applications for new program to shorten drug approval times
- STATSTAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more
- STATSTAT+: A Sellas immunotherapy study, long delayed, will end in failure
- STATSTAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more
- STATSTAT+: FDA has too few staffers to hire more staff
- STATSTAT+: New startup to test psychedelic-like drug against Parkinson’s symptom
- FortuneFormer White House economist: science has delivered a cancer detection revolution, now the FDA must keep pace
- STATSTAT+: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
- KFF Health NewsThe Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren’t Done.
- STATSTAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more
- STATSTAT+: Up and down the ladder: The latest comings and goings
- STATSTAT+: Roche expands its Boston footprint with new research center
Sources
Every article we clustered into this story. Headlines link to the publisher.
- STAT+: Roche expands its Boston footprint with new research center STAT
- STAT+: Up and down the ladder: The latest comings and goings STAT
- STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more STAT
- The Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren’t Done. KFF Health News
- STAT+: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease STAT
- Former White House economist: science has delivered a cancer detection revolution, now the FDA must keep pace Fortune
Show 6 more sources
- STAT+: New startup to test psychedelic-like drug against Parkinson’s symptom STAT
- STAT+: FDA has too few staffers to hire more staff STAT
- STAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more STAT
- STAT+: A Sellas immunotherapy study, long delayed, will end in failure STAT
- STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more STAT
- STAT+: FDA takes applications for new program to shorten drug approval times STAT
In this story
- FDA
- Roche
- Xenon Pharma
- Sellas
- Bavarian Nordic